Clinical outcomes and biomarker profiles of elderly pretreated NSCLC patients from the BATTLE trial.
about
How old is "too old" for translational research?DeMix: deconvolution for mixed cancer transcriptomes using raw measured data.Management of elderly patients.A tale of two approaches: complementary mechanisms of cytotoxic and targeted therapy resistance may inform next-generation cancer treatmentsProspective validation of quantitative NSE mRNA in pleural fluid of non-small cell lung cancer patients.Management of elderly patients with NSCLC; updated expert's opinion paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for Geriatric Oncology.
P2860
Clinical outcomes and biomarker profiles of elderly pretreated NSCLC patients from the BATTLE trial.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Clinical outcomes and biomarke ...... atients from the BATTLE trial.
@en
Clinical outcomes and biomarke ...... atients from the BATTLE trial.
@nl
type
label
Clinical outcomes and biomarke ...... atients from the BATTLE trial.
@en
Clinical outcomes and biomarke ...... atients from the BATTLE trial.
@nl
prefLabel
Clinical outcomes and biomarke ...... atients from the BATTLE trial.
@en
Clinical outcomes and biomarke ...... atients from the BATTLE trial.
@nl
P2093
P2860
P50
P1476
Clinical outcomes and biomarke ...... atients from the BATTLE trial.
@en
P2093
Anne S Tsao
Christine Alden
David Stewart
Edward Kim
J Jack Lee
Scott Lippman
Suzanne E Davis
Waun Ki Hong
Xi Ming Tang
P2860
P304
P356
10.1097/JTO.0B013E31826910FF
P577
2012-11-01T00:00:00Z